The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference (2012)
- Autores:
- Autor USP: WRENGER, CARSTEN - ICB
- Unidade: ICB
- DOI: 10.1042/BJ20111542
- Assunto: PARASITOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Biochemical Journal
- ISSN: 1470-8728
- Volume/Número/Paginação/Ano: v. 443, n. 2, p. 397-405, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KNÖCKEL, Julia et al. The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference. Biochemical Journal, v. 443, n. 2, p. 397-405, 2012Tradução . . Disponível em: https://doi.org/10.1042/BJ20111542. Acesso em: 16 abr. 2024. -
APA
Knöckel, J., Müller, I. B., Butzloff, S., Bergmann, B., Walter, R. D., & Wrenger, C. (2012). The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference. Biochemical Journal, 443( 2), 397-405. doi:10.1042/BJ20111542 -
NLM
Knöckel J, Müller IB, Butzloff S, Bergmann B, Walter RD, Wrenger C. The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference [Internet]. Biochemical Journal. 2012 ; 443( 2): 397-405.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1042/BJ20111542 -
Vancouver
Knöckel J, Müller IB, Butzloff S, Bergmann B, Walter RD, Wrenger C. The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference [Internet]. Biochemical Journal. 2012 ; 443( 2): 397-405.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1042/BJ20111542 - Cytometric quantification of singlet oxygen in the human malaria parasite Plasmodium falciparum
- Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target?
- The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation
- Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but... how to deal with them?
- Chemical and genetic validation of thiamine utilization as an antimalarial drug target
- Harnessing the helminth secretome for therapeutic immunomodulators
- MRSA infections: from classical treatment to suicide drugs
- Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles
- Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro
- Structure of ThiM from Vitamin B1 biosynthetic pathway of Staphylococcus aureus – Insights into a novel pro-drug approach addressing MRSA infections
Informações sobre o DOI: 10.1042/BJ20111542 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas